What DOGE’s actions mean for U.S. healthcare
HFMA Senior Editor Rich Daly talks about his hfm cover story about DOGE and the healthcare industry. HFMA’s Nick Hut and Shawn Stack talk about the 340B drug pricing program.
2025-2026 healthcare policies timeline
The Trump administration and the Republican-led Congress have launched a flurry of healthcare initiatives and proposals since their first days. To help readers keep track of the wave of initiatives, below is a timeline of federal actions and our related coverage. All dates below are for 2025, unless marked “2026.” Executive Actions Jan. 17: Trump…
What DOGE’s actions mean for U.S. healthcare
The federal government’s perennial search for fraud, waste and abuse (FWA) in its healthcare spending has become a key focus of the Trump administration and could presage deeper financial changes. The gathering storm has left health systems scrambling to prepare for the major financial headwinds that could come from the initiatives. President Donald Trump has…
Ken Perez: Trump’s second administration promises a shakeup around health policy
What a difference eight years can make. On Jan. 20, 2017, his first day in office as the nation’s 45th president, Donald Trump issued just one executive order (EO), scaling back parts of the Affordable Care Act (ACA). It set the stage for Congress’ subsequent repeal, via the Tax Cuts and Jobs Act of 2017,…
Healthcare developments in a second Trump term
Nick Hut and Shawn Stack discuss early developments in healthcare policy now that Donald Trump has taken office for a second time.
4 bipartisan healthcare policy changes are likely in 2025
HFMA policy experts see a high likelihood for far-reaching changes in healthcare policy following the November elections, with a focus on four areas: site-neutral payments, prior authorization, the 340B Drug Pricing Program, and mergers and acquisitions (M&A). The elections could produce a range of outcomes for the presidency and control of Congress. However, strong bipartisan…
Scrutiny in the Steward Health Care scandal
Nick Hut and Shawn Stack discuss the continuing bankruptcy proceedings of Steward Health Care and refusal of system CEO Ralph de la Torre to testify before the Senate.
News Briefs: Supreme Court ruling on Chevron makes regulations more vulnerable to legal challenges
The Supreme Court issued a decision June 28 that has dramatic implications for the regulatory infrastructure in healthcare, among many other industries. Under the Supreme Court’s 1984 Chevron v. Natural Resources Defense Council decision, courts were guided to give deference in their rulings to federal regulatory authorities such as CMS. Such agencies were deemed to…
Annual Conference Day 1: HFMA, AHA leaders hold forth on the state of the healthcare industry
HFMA’s 2024 Annual Conference began Monday afternoon with HFMA’s Ann Jordan and the American Hospital Association’s Rick Pollack rallying attendees to address the profound challenges and opportunities facing the industry. To start, Jordan, HFMA’s president and CEO, highlighted the conference theme, “A New Frontier in Health.” Frontier is “an exciting and unsettling word that really…
CMS’s 2024 MA rule brings some improvements but falls short of addressing all providers’ concerns
Hospitals and other healthcare providers welcomed CMS’s release in 2023 of the 2024 Medicare Advantage and Part D final rule (CMS-4201-F).a The rule represents CMS’s effort to refine the practices of MA organizations by placing limitations on prior authorization, elevating requirements for provider directories and making comprehensive adjustments to the MA and Part D quality…